Late recurrence of renal cell carcinoma >5 years after surgery: Clinicopathological characteristics and prognosis

BJU International

Volumn 110, Issue 11 B, 2012, Pages

  Park, Yong Hyun ^a   Baik, Kyung Don ^a   Lee, Young Ju ^a   Ku, Ja Hyeon ^a   Kim, Hyeon Hoe ^a   Kwak, Cheol ^a  

^a Seoul National University   (South Korea)

Author keywords

Late recurrence; Predictive factors; Renal cell carcinoma

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURVIVAL RATE; SYMPTOM; THROMBOCYTE COUNT; TUMOR INVASION; COMPARATIVE STUDY; FOLLOW UP; INCIDENCE; KIDNEY TUMOR; MIDDLE AGED; NEPHRECTOMY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK; SOUTH KOREA; TIME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; ODDS RATIO; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84876451048     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11246.x     Document Type: Article

References (14)

1. McNichols DW, Segura JW, DeWeerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981 ; 126 : 17-23
2. Nakano E, Fujioka H, Matsuda M, Osafune M, Takaha M, Sonoda T. Late recurrence of renal cell carcinoma after nephrectomy. Eur Urol 1984 ; 10 : 347-9
3. Miyao N, Naito S, Ozono S et al. Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. Urology 2011 ; 77 : 379-84
4. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996 ; 335 : 865-75
5. Bukowski RM. Systemic therapy for metastatic renal cell carcinoma in treatment naive patients: a risk-based approach. Expert Opin Pharmacother 2010 ; 11 : 2351-62
6. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010 ; 17 : 1471-4
7. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J Pathol 1997 ; 183 : 131-3
8. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982 ; 6 : 655-63
9. Adamy A, Chong KT, Chade D et al. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. J Urol 2011 ; 185 : 433-8
10. Yerushalmi R, Tyldesley S, Kennecke H et al. Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Ann Oncol 2012 ; 23 : 338-45
11. Epiney M, Bertossa C, Weil A, Campana A, Bischof P. CA125 production by the peritoneum: in-vitro and in-vivo studies. Hum Reprod 2000 ; 15 : 1261-5
12. Daoud E, Bodor G. CA-125 concentrations in malignant and nonmalignant disease. Clin Chem 1991 ; 37 : 1968-74
13. Koo JS, Jung W, Jeong J. Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site. Tumori 2010 ; 96 : 424-32
14. Bruin SC, Klijn C, Liefers GJ et al. Specific genomic aberrations in primary colorectal cancer are associated with liver metastases. BMC Cancer 2010 ; 10 : 662-73